Cost Minimization Analysis (CMA) Penggunaan Obat Captopril dan Lisinopril pada Pasien Hipertensi di RSUD Sultan Suriansyah Banjarmasin

Cost Minimization Analysis (CMA) Use of Captopril and Lisinopril Drugs in Hypertensive Patients at Sultan Suriansyah Hospital Banjarmasin

Authors

  • Nailul Muna Universitas Sari Mulia
  • Melviani Melviani Universitas Sari Mulia
  • Erlina Syamsu Universitas Sari Mulia

DOI:

https://doi.org/10.33084/jsm.v9i2.4015

Keywords:

Captopril, Cost-minimize, Hypertension, Lisinopril

Abstract

Hypertension is a world health problem leading to increased morbidity and mortality, as well as burdening the cost of health services, including in Indonesia. Cost Minimal hypertension treatment can reduce the high incidence of hypertension. The purpose of this study was to determine the cost that is more cost-minimize among  the use of captopril and lisinopril in outpatient hypertension patients at Sultan Suriansyah Hospital  Banjarmasin. This study is an analytic with a design  cross sectional. Data collection is done by looking at the medical records of hypertensive patients  outpatient hospital Sultan Suriansyah Banjarmasin who received antihypertensive therapy captopril and lisinopril. The sampling method used is non-probability  sampling by using the technique purposive non-random sampling. Samples that  35 patients were used. The cost component measured is direct medical costs  outpatient hypertensive patients which includes the cost of antihypertensive drugs, the cost of disease drugs  participants, laboratory fees, and consulting fees. The results showed that the average total direct medical cost in the captopril group was Rp127.886 and the group  lisinopril Rp.274.971.  In the captopril group it has a more minimal cost  compared with the lisinopril group. 

Downloads

Download data is not yet available.

Author Biographies

Nailul Muna, Universitas Sari Mulia

https://unism.ac.id/

Melviani Melviani, Universitas Sari Mulia

https://unism.ac.id/

Erlina Syamsu, Universitas Sari Mulia

https://unism.ac.id/

References

Alifiar, I., & Idacahyati, K. (2019). Kajian Farmakoekonomi Penggunaan Obat Antihipertensi Pada Pasien Hipertensi Yang Dirawat Di RSUD Kota Tasikmalaya. Jurnal Pharmascience, Vol 5 No 2, 126–133.
Dewi, M. I. K., Prabowo, W. C., & Rusli, R. (2019). Analisis Biaya Minimal Penggunaan Antihipertensi Di Rumah Sakit Umum Daerah Kota Bontang. Proceeding of Mulawarman Pharmaceuticals Conferences, 9(1 SE-Articles), 27–31.
Hasan, A. (2018). Korelasi Umur dan Jenis Kelamin dengan Penyakit Hipertensi di Emergency Center Unit Rumah Sakit Islam Siti Khadijah Palembang 2017. Indonesia Jurnal Perawat, 3(1), 9–16.
Hastuti, A, and M. K. (2020). Hipertensi. Penerbit Lakeisha [Diakses : 7/02/22]
Indrayathi, P. A. (2016). Bahan Ajar Economic Evaluation In Health Care.
James, P. A., Et Al (2014). 2014 Evidence-Based Guideline For The Management Of High Blood Pressure In Adults Report From The Panel Members Appointed To The Eighth Joint National Committee (JNC 8) Clinical Review & Education Special Communication 507. JAMA, 311(5), 507–520.
Jameson, J. L., Fauci, A. S., Kasper, D. L., Hauser, S. L., Longo, D. L., & Loscalzo, J. (2020). Hypertension. In Harrison’s Manual Of Medicine, 20e. Mcgraw-Hill Education.
Kementerian Kesehatan Republik Indonesia. (2018). Laporan Nasional Riset Kesehatan Dasar. Kementrian Kesehatan RI, 1–582.
Kementerian Kesehatan Republik Indonesia. (2019). Laporan Nasional Riset Kesehatan Dasar Kalimantan Selatan.
Kementerian Kesehatan Republik Indonesia. (2020). Laporan Nasional Riset Kesehatan Dasar Kalimantan Selatan.
Merliana, H. (2017). Analisis Minimisasi Biaya Amlodipin Generik Dan Bermerk Pada Pengobatan Hipertensi Di RS X Pekanbaru Tahun 2015. Jurnal Ekonomi Kesehatan Indonesia, 1(3), 114–119.
Nugraheni, D. A., & Andayani, T. M. (2015). Cost - Minimization Analysis Kaptopril Dibandingkan Lisinopril Pada Pasien Hipertensi Rawat Jalan. Jurnal Farmasi Indonesia, Vol 12 No 2 (2015): Jurnal Farmasi Indonesia, 179–189.
Perhimpunan Dokter Hipertensi Indonesia. (2019). Konsensus Hipertensi. 118.
Rai, M., & Goyal, R. (2018). Pharmacoeconomics In Healthcare. Pharmaceutical Medicine And Translational Clinical Research, 465–472.
Sukandar. (2013). ISO Farmakoterapi I. In PT ISFI Penerbitan: Jakarta (P. ISFI Jakarta-ISFI Jakarta).
Suryonegoro, S. B., Elfa, M. M., Noor, M. S., Studi, P., Dokter, P., Kedokteran, F., Mangkurat, U. L., Ilmu, D., Dalam, P., Ilmu, D., Masyarakat, K., & Kedokteran, F. (2021). Literature Review: Hubungan Hipertensi pada Wanita Menopause dan Usia Lanjut terhadap Kualitas Hidup. Homeostasis: Jurnal Mahasiswa Pendidikan Dokter, 4(2), 387–398.
Utari, A. B., & Rochmah, T. N. (2018). Cost Of Hypertension Disease In Kediri Regency. Inahea 2017, 272–276.
Widjadja. (2018). Hubungan Keluarga Dengan Tingkat Kepatuhan Diet Rendah Garam Pada Penderita Hipertensi Di Rumah Sakit Dr. Saiful Anwar Malang.
Zuela, S. (2021). Keperawatan Medikal Bedah. Bcg, 200.

Downloads

Published

2023-08-27

How to Cite

Muna, N., Melviani, M., & Syamsu, E. (2023). Cost Minimization Analysis (CMA) Penggunaan Obat Captopril dan Lisinopril pada Pasien Hipertensi di RSUD Sultan Suriansyah Banjarmasin: Cost Minimization Analysis (CMA) Use of Captopril and Lisinopril Drugs in Hypertensive Patients at Sultan Suriansyah Hospital Banjarmasin. Jurnal Surya Medika (JSM), 9(2), 18–25. https://doi.org/10.33084/jsm.v9i2.4015

Issue

Vol. 9 No. 2 (2023): Jurnal Surya Medika (JSM)

Section

Articles

License

Copyright (c) 2023 Nailul Muna, Melviani Melviani, Erlina Syamsu

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

All rights reserved. This publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording.